This public procurement record has 2 releases in its history.

Award

27 Apr 2023 at 14:59

Tender

17 Jan 2023 at 12:40

Summary of the contracting process

The NHS England has awarded a contract for the NHS National Pharmaceuticals Dasatinib and Paliperidone Injection under a framework agreement. The tender had the identifier CM/PHG/22/5694 and was classified under the CPV code 33600000 for pharmaceutical products. The contract covered two lots, each with specific call-off periods within the framework agreement. The procurement stage was completed, and the contract was awarded to multiple suppliers, including Zentiva Pharma UK Ltd, Teva UK Limited, Mylan, and Janssen-Cilag Ltd. The contract value was 1.0 GBP, signed on 21st February 2023.

This tender by NHS England offers business growth opportunities for suppliers of pharmaceutical products. The procurement method was an open procedure with a tender period ending on 21st February 2023. Key dates include various call-off periods for the lots and a bid opening date of 21st February 2023. Businesses in the pharmaceutical industry, particularly suppliers of Dasatinib and Paliperidone Injection, would be well-suited to compete in this tender to supply NHS England and other participating NHS bodies.

How relevant is this notice?

Notice Title

NHS National Pharmaceuticals Dasatinib and Paliperidone Injection

Notice Description

Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694<br/><br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW 01/05/2023 - 30/04/2024 - (12 Months) <br/>LSNE 01/05/2023 - 30/04/2024 - (12 Months)<br/>NWLN 01/05/2023 - 30/04/2024 - (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE 01/05/2023 - 31/05/2024 (13 Months) <br/>NWLN 01/05/2023 - 31/01/2025 (21 months)

Lot Information

5. Lot 2 CM/PHG/22/5694/01 Supplier offer confirmation (check box)

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:

CM/PHG/22/5694/00 - Dasatinib
CESW - 01/05/2023 - 30/04/2024 - (12 Months)
LSNE - 01/05/2023 - 30/04/2024 - (12 Months)
NWLN - 01/05/2023 - 30/04/2024 - (12 Months)

CM/PHG/22/5694/01 - Paliperidone Injection:
LSNE - 01/05/2023 - 31/05/2024 (13 Months)
NWLN - 01/05/2023 - 31/01/2025 (21 months)

Options: Options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

4. Lot 1 CM/PHG/22/5694/00 Supplier offer confirmation (check box)

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:

CM/PHG/22/5694/00 - Dasatinib
CESW - 01/05/2023 - 30/04/2024 - (12 Months)
LSNE - 01/05/2023 - 30/04/2024 - (12 Months)
NWLN - 01/05/2023 - 30/04/2024 - (12 Months)

CM/PHG/22/5694/01 - Paliperidone Injection:
LSNE - 01/05/2023 - 31/05/2024 (13 Months)
NWLN - 01/05/2023 - 31/01/2025 (21 months)

Options: Option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-03981f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/012161-2023
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£108,792,862 £100M-£1B
Lots Value
£60,373,911 £10M-£100M
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
27 Apr 20233 years ago
Submission Deadline
21 Feb 2023Expired
Future Notice Date
Not specified
Award Date
21 Feb 20233 years ago
Contract Period
1 May 2023 - 30 Apr 2024 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
5
Supplier Names

Janssen-Cilag Ltd

Mercury Pharmaceuticals Limited

Mylan

Teva UK Limited

Zentiva Pharma UK Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...